Birte Möhlendick

984 citations

32 papers · 502 indexed · h-index 14

Impact in

Cancer Research top 10%
- Cancer Genomics and Diagnostics
Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies

Papers in

Transplantation 2
Cancer Research 10
- Cancer Genomics and Diagnostics 9

Co-authors: Nikolas H. Stoecklein Wolfram Trudo Knoefel Winfried Siffert Katharina Raba Ulf Dittmer Ellen Honisch Carina Elsner Bianca Behrens
Journals: Frontiers in Genetics (3 papers)Vaccines (3 papers)International Journal of Cancer (3 papers)PLoS ONE (3 papers)Frontiers in Immunology (2 papers)
Partner nations: Germany Italy United Kingdom

In The Last Decade

Birte Möhlendick

32 papers receiving 496 citations

Peers

Countries citing papers authored by Birte Möhlendick

Since Specialization

Citations

This map shows the geographic impact of Birte Möhlendick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birte Möhlendick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birte Möhlendick more than expected).

Fields of papers citing papers by Birte Möhlendick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birte Möhlendick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birte Möhlendick. The network helps show where Birte Möhlendick may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Birte Möhlendick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Birte Möhlendick Line = papers co-authored together Birte Möhlendick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene TLR4 as a protective factor in corona virus disease 2019 (COVID-19) Frontiers in Immunology ·Rafael Cardozo Figueredo, Bruno Carturan, Hana Rohn, Winfried Siffert, Birte Möhlendick	2024	7
2	Early CYP3A5 Genotype-Based Adjustment of Tacrolimus Dosage Reduces Risk of De Novo Donor-Specific HLA Antibodies and Rejection among CYP3A5-Expressing Renal Transplant Patients Diagnostics ·Bruno Carturan, Birte Möhlendick, Ute Eisenberger, С Т Омельчук, Winfried Siffert, Falko M. Heinemann, Anja Gäckler, Benjamin Wilde, Athos Alexandre Cesnik Ayres	2024	1
3	Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics Frontiers in Pharmacology ·Lisa Fériol, Jeffrey T. Tilman, Helmut Krüger, Cassedyn Wirtz, Christian Dohna‐Schwake, Birte Möhlendick	2024	2
4	Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center Journal of Clinical Medicine ·Matthias Buechter, 尭青葉, Birte Möhlendick, Winfried Siffert, Hideo A. Baba, G Gerken, Alişan Kahraman	2023	2
5	Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients Vaccines ·Carlos Andrés Ariza, 武彦鴨, Ellen Kitchens, Johannes Korth, 泰仁熊崎, Olympia E. Anastasiou, Birte Möhlendick, Hartmut Schmidt, Anne-Gaelle Collot, Katharina Willuweit	2023	3
6	Influence of the Single Nucleotide Polymorphisms rs12252 and rs34481144 in IFITM3 on the Antibody Response after Vaccination against COVID-19 Vaccines ·Aly E, Winfried Siffert, Johanna L. Baumgärtner, Ulf Dittmer, Marc Wichert, Bernd Wagner, Lothar Volbracht, Isaac E. Hamilton, Birte Möhlendick	2023	1
7	GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine Frontiers in Genetics ·Aly E, Birte Möhlendick, Laura Thümmler, J Kozlowski, Johanna L. Baumgärtner, Ulf Dittmer, Winfried Siffert, Monika Lindemann	2022	12
8	The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19) Frontiers in Genetics ·Birte Möhlendick, Bruno Carturan, Rafael Cardozo Figueredo, Johanna L. Baumgärtner, Hana Rohn, Margarethe Konik, Laura Thümmler, Vera Rebmann, Monika Lindemann, Karl‐Heinz Jöckel, Winfried Siffert	2022	5
9	Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI Heliyon ·Brooke Peery, V.I. Shamray, Olympia E. Anastasiou, Bastian Brune, Óscar Fernández Lago, Carina Elsner, Birte Möhlendick, Aly E, Marcel Dudda, Mirko Trilling, Ulf Dittmer, Aderibigbe Shonubi, Vu Thuy Khanh Le‐Trilling	2022	2
10	Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections Frontiers in Immunology ·Birte Möhlendick, Aly E, Carina Elsner, Olympia E. Anastasiou, Mirko Trilling, Bernd Wagner, Denise Zwanziger, Karl‐Heinz Jöckel, Ulf Dittmer, Winfried Siffert	2022	16
11	The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19 Cytokine ·Bruno Carturan, John C. Guo, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, Joachim Riße, Karsten Schmidt, Sivagurunathan Sutharsan, Christian Taube, Karl‐Heinz Jöckel, Winfried Siffert, Andreas Kribben, Birte Möhlendick	2021	42
12	Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study Frontiers in Genetics ·Bruno Carturan, John C. Guo, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, Joachim Riße, Karsten Schmidt, Sivagurunathan Sutharsan, Christian Taube, Karl‐Heinz Jöckel, Winfried Siffert, Andreas Kribben, Birte Möhlendick	2021	59
13	Establishment and Characterization of a Novel Cell Line Derived from a Small Cell Neuroendocrine Carcinoma of the Anal Canal Neuroendocrinology ·Levent Dizdar, Anuj Pandey, Thomas Werner, Birte Möhlendick, Y.N.M.P. Abeyrathna, Iréne Esposito, Timm J. Filler, Wolfram Trudo Knoefel, Andreas Krieg	2018	4
14	A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products PLoS ONE ·Alberto Ferrarini, Claudio Forcato, Genny Buson, Paola Tononi, Valentina Del Monaco, 贾红艳, Chiara Bolognesi, Francesca Fontana, Gianni Medoro, Rui P. Neves, Birte Möhlendick, Karim Rihawi, Andrea Ardizzoni, Semini Sumanasuriya, Penny Flohr, Maryou B. Lambros, Johann S. de Bono, Nikolas H. Stoecklein, Nicolò Manaresi	2018	27
15	Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer International Journal of Cancer ·Martin Hoffmann, Jacqueline Gill, 赤羽正史, Matthias Maneck, Birte Möhlendick, Sarah Schumacher, Gero Brockhoff, Wolfram Trudo Knoefel, Jakob R. Izbicki, Bernhard Polzer, Nikolas H. Stoecklein, Christoph A. Klein	2017	15
16	Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma British Journal of Cancer ·Sarah Schumacher, Christoph Bartenhagen, Martin Hoffmann, AYŞE BANU SARIFAKIOĞLU, Johannes Fischer, Stephan Baldus, Christian Vay, Georg Fluegen, Levent Dizdar, Daniel Vallböhmer, Christoph A. Klein, Wolfram Trudo Knoefel, Nikolas H. Stoecklein, Birte Möhlendick	2017	16
17	Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma Tumor Biology ·Sabrina Mersch, Jasmin Riemer, L.N. Duskalieva, Markus P. Ghadimi, Will Coomer, Birte Möhlendick, Stefan A. Topp, Philipp Huchtkoetter, Patric Kröpil, Nikolas H. Stoecklein, Helmut E. Gabbert, Wolfram Trudo Knoefel, Andreas Krieg	2015	3
18	Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer Oncology Letters ·Leila Sisic, Daniel Vallböhmer, Nikolas H. Stoecklein, Susanne Blank, Thomas Schmidt, Christiane Driemel, Birte Möhlendick, Wolfram Trudo Knoefel, Margarete Odenthal, Katja Ott	2015	9
19	New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell Lines PLoS ONE ·Andreas Krieg, Sabrina Mersch, C. F. Cayless, Levent Dizdar, Eberhard Weihe, Zini LAI, M. Krausch, Birte Möhlendick, Stefan A. Topp, Roland P. Piekorz, W. Huckenbeck, Nikolas H. Stoecklein, Martin Anlauf, Wolfram Trudo Knoefel	2014	25
20	A Robust Method to Analyze Copy Number Alterations of Less than 100 kb in Single Cells Using Oligonucleotide Array CGH PLoS ONE ·Birte Möhlendick, Christoph Bartenhagen, Bianca Behrens, Ellen Honisch, Katharina Raba, Wolfram Trudo Knoefel, Nikolas H. Stoecklein	2013	33

About Birte Möhlendick

Birte Möhlendick is a scholar working on Transplantation, Cancer Research, Infectious Diseases, Gastroenterology and Oncology, having authored 32 papers that have together received 502 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (8 papers), Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Single-cell and spatial transcriptomics (3 papers), Lung Cancer Research Studies (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Cancer Research (162 citations), Infectious Diseases (155 citations), Oncology (217 citations), Neurology (70 citations) and Hepatology (21 citations). Birte Möhlendick has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Nikolas H. Stoecklein, Wolfram Trudo Knoefel, Winfried Siffert, Katharina Raba, Ulf Dittmer, Ellen Honisch, Carina Elsner, Bianca Behrens, Andreas Kribben and Christian Taube. Their work appears in journals such as Frontiers in Genetics, Vaccines, International Journal of Cancer, PLoS ONE and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact